Citation Impact
Citing Papers
Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation
2009 Standout
Classification and natural history of clinically identifiable subtypes of cerebral infarction
1991 Standout
Clopidogrel with or without Omeprazole in Coronary Artery Disease
2010 Standout
Short- and long-term oral antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention
2003
New Antithrombotic Drugs
2012
Platelet-Active Drugs
1998
The thienopyridine ticlopidine selectively prevents the inhibitory effects of ADP but not of adrenaline on cAMP levels raised by stimulation of the adenylate cyclase of human platelets by PGE1
1990
Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
2014 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Early and Sustained Dual Oral Antiplatelet Therapy Following Percutaneous Coronary Intervention
2002 Standout
P2Y12Receptors in Spinal Microglia Are Required for Neuropathic Pain after Peripheral Nerve Injury
2008
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
2009 Standout
Coronary heart disease: seven dietary factors
1991 Standout
The P2Y1 receptor, necessary but not sufficient to support full ADP‐induced platelet aggregation, is not the target of the drug clopidogrel
1998
Effect of 300- and 450-mg clopidogrel loading doses on membrane and soluble P-selectin in patients undergoing coronary stent implantation
2002
THE CANADIAN AMERICAN TICLOPIDINE STUDY (CATS) IN THROMBOEMBOLIC STROKE
1989
Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle
1994 StandoutNature
Platelet Activation and Atherothrombosis
2007 Standout
Clopidogrel with Aspirin in Acute Minor Stroke or Transient Ischemic Attack
2013 Standout
Antiplatelet Drugs
2012
Structure and Stereochemistry of the Active Metabolite of Clopidogrel
2002
Pharmacology of Antiplatelet Agents
2013
2-Amino-1,3,4-thiadiazoles in the 7-hydroxy-N-neopentyl spiropiperidine indolinyl series as potent P2Y1 receptor antagonists
2014
EFFECTS OF CHANGES IN FAT, FISH, AND FIBRE INTAKES ON DEATH AND MYOCARDIAL REINFARCTION: DIET AND REINFARCTION TRIAL (DART)
1989 Standout
Abnormal Endothelium-Dependent Vascular Relaxation in Patients with Essential Hypertension
1990 Standout
P2Y12, a New Platelet ADP Receptor, Target of Clopidogrel
2001
Cellular and Molecular Mechanisms of Pain
2009 StandoutNobel
The P2Y12 receptor regulates microglial activation by extracellular nucleotides
2006 StandoutNobel
Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study
2001 Standout
Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin
2001 Standout
Identification of the platelet ADP receptor targeted by antithrombotic drugs
2001 StandoutNatureNobel
Platelet-Active Drugs
2001
Platelet-Active Drugs: The Relationships Among Dose, Effectiveness, and Side Effects
2004
Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
2007 Standout
Standardized Bleeding Definitions for Cardiovascular Clinical Trials
2011 Standout
Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial
2006 Standout
Acute Antithrombotic Effect of a Front-Loaded Regimen of Clopidogrel in Patients With Atherosclerosis on Aspirin
2000
Atrial natriuretic factor elicits an endothelium-independent relaxation and activates particulate guanylate cyclase in vascular smooth muscle.
1984 StandoutNobel
Role of endothelium in responses of vascular smooth muscle.
1983 StandoutNobel
Endothelium-dependent relaxation in rat aorta may be mediated through cyclic GMP-dependent protein phosphorylation
1983 StandoutNatureNobel
The Effect of Cod Liver Oil and Corn Oil on Platelets and Vessel Wall in Man
1981
Clopidogrel Versus Dipyridamole in Addition to Aspirin in Reducing Embolization Detected With Ambulatory Transcranial Doppler
2011
Acute Hemodynamic Interaction of Aspirin and Ticlopidine With Enalapril
1998
Identification and Biological Activity of the Active Metabolite of Clopidogrel
2000
Cyclic guanosine monophosphate as a mediator of vasodilation.
1986 StandoutNobel
Catalytic Enantioselective Conversion of Epoxides to Thiiranes
2016 StandoutNobel
Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation
2001 Standout
Highly Selective Copper-Catalyzed Ring Expansion of Vinyl Thiiranes: Application to Synthesis of Biotin and the Heterocyclic Core of Plavix
2007
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein.
1989 StandoutNobel
Addition of clopidogrel to aspirin in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trial
2005
Chromone: A Valid Scaffold in Medicinal Chemistry
2014 Standout
Ultrastructural Studies of Platelet Aggregates From Human Subjects Receiving Clopidogrel and From a Patient With an Inherited Defect of an ADP-Dependent Pathway of Platelet Activation
1996
Mechanisms of adenosine triphosphate-, thrombin-, and trypsin-induced relaxation of rat thoracic aorta.
1984 StandoutNobel
Basic polyamino acids rich in arginine, lysine, or ornithine cause both enhancement of and refractoriness to formation of endothelium-derived nitric oxide in pulmonary artery and vein.
1989 StandoutNobel
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Role of endothelium-derived nitric oxide in the regulation of blood pressure.
1989 Standout
The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme. Rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease
2000
Role of Prostacyclin in the Cardiovascular Response to Thromboxane A 2
2002 StandoutScience
Diastereoselective Allylation of Carbonyl Compounds and Imines: Application to the Synthesis of Natural Products
2013 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
2012 Standout
Aromatic Sulfonyl Fluorides Covalently Kinetically Stabilize Transthyretin to Prevent Amyloidogenesis while Affording a Fluorescent Conjugate
2013 StandoutNobel
Signal Transduction Using Nitric Oxide and Cyclic Guanosine Monophosphate
1996 StandoutNobel
Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells.
1991 StandoutNobel
The Antiaggregating and Antithrombotic Activity of Clopidogrel Is Potentiated by Aspirin in Several Experimental Models in the Rabbit
1998
Applications of Palladium-Catalyzed C–N Cross-Coupling Reactions
2016 Standout
Inhibition of platelet function by cis-unsaturated fatty acids
1984
Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide.
1987 Standout
The nature of endothelium-derived vascular relaxant factor
1984 Nature
Agonist-induced endothelium-dependent relaxation in rat thoracic aorta may be mediated through cGMP.
1983 StandoutNobel
Phospholipase A2Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention
2011 Standout
Effect of sodium-potassium pump inhibitors and membrane-depolarizing agents on sodium nitroprusside-induced relaxation and cyclic guanosine monophosphate accumulation in rat aorta.
1985 StandoutNobel
Mechanism of Oxidation Reactions Catalyzed by Cytochrome P450 Enzymes
2004 Standout
Synthesis and Applications of tert-Butanesulfinamide
2010
Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical.
1987 StandoutNobel
Thimerosal induces endothelium-dependent vascular smooth muscle relaxations by interacting with thiol groups
1986
Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor
1986 StandoutNature
Cobra venom phospholipase A2 inhibition by manoalide. A novel type of phospholipase inhibitor.
1985
NG-methyl-L-arginine causes endothelium-dependent contraction and inhibition of cyclic GMP formation in artery and vein.
1990 StandoutNobel
Works of E. Vallée being referenced
Broad spectrum anti-platelet activity of ticlopidine and PCR 4099 involves the suppression of the effects of released ADP
1987
The role of platelets and ADP in experimental thrombosis induced by venous stasis in the rat
1988
Anti-inflammatory and platelet anti-aggregant activity of phospholipase-A2 inhibitors
1979
Ticlopidine: A Promise for the Prevention and Treatment of Thrombosis and Its Complications
1983
Clopidogrel, A Novel Antiplatelet and Antithrombotic Agent
1993
Inhibition of platelet phospholipase-A2 as a mechanism for the anti-aggregating effect of linoleic acid
1980